Article Details
Retrieved on: 2025-06-03 01:09:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pelage Pharmaceuticals recently announced its novel topical agent, PP405, has advanced to a phase 2a study for androgenetic alopecia, with enrollment ...
Article found on: dermatologytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here